In an effort to combat extensive drug-resistance in gonorrhea, a new assay identifies patients who may still have a response to an older, less reliable therapy.
Survivors of anal cancer have an elevated risk of HPV-related second primary malignancies.
Expedited partner therapy associated with lower rates of sexually transmitted infections.
Because MSM represent the majority of all primary and secondary syphilis cases, addressing the high rates of syphilis among MSM is essential to the success of syphilis prevention programs.
Self-persuasion method facilitates HPV vaccination better than external persuasion in low literacy, safety-net settings.
HPV vaccine has the potential to reverse the epidemic and prevent thousands of cancers in the United States each year.
The American Society of Clinical Oncology issued new recommendations based on 4 levels of resource settings on human papillomavirus vaccination for cervical cancer prevention.
A randomized trial shows that a candidate HSV-2 vaccine had a favorable safety profile and led to reduced shedding and lesion rates in human participants.
After a 30-minute educational session with high school seniors, basic knowledge of human papillomavirus and the benefits of HPV vaccination significantly increased.
Sexually active teens reported to not to seek out STD services due to confidentiality issues.
Distant metastases rates are up in patients with HPV-positive oropharyngeal cancer, who actively smoke or have T4 tumors.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Infections Complicate Biologic Use in Autoimmune Inflammatory Disorders
- Some Antibiotics May Reduce Biofilm in Urinary Tract Infections
- Tuberculosis Vaccine May Reverse Type 1 Diabetes
- Sepsis-Related Mortality Decreased With Rapid Implementation of Protocol
- New Assay Targets Susceptibility to Ciprofloxacin in Gonorrhea
- Increased Incidence of Chlamydia Due to Changes in Cancer Screening Guidelines
- Serratia marcescens Outbreak After Drug Tampering in US Hospital
- Meningococcal Disease Risk Linked to Eculizumab Despite Vaccination
- Medicaid Enrollees Largely Satisfied With Their Health Care
- Ebola Vaccine Long-Term Safety and Antibody Response